Altimmune (ALT) director granted 48,800 stock options at $2.82 exercise price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Altimmune, Inc. director Philip Hodges received a grant of stock options as part of his non-employee director compensation. The award covers 48,800 options to buy common stock at an exercise price of $2.82 per share, expiring on May 1, 2036.
The 48,800 underlying shares become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, as long as Hodges continues to serve the company through each vesting date. This is a compensation-related award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hodges Philip
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (option to buy) | 48,800 | $0.00 | -- |
Holdings After Transaction:
Stock Options (option to buy) — 48,800 shares (Direct, null)
Footnotes (1)
- The options were granted pursuant to the Company's non-employee director compensation policy. The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date.
Key Figures
Options granted: 48,800 options
Exercise price: $2.82 per share
Expiration date: May 1, 2036
+3 more
6 metrics
Options granted
48,800 options
Stock options to buy Altimmune common stock granted to director
Exercise price
$2.82 per share
Conversion or exercise price of granted options
Expiration date
May 1, 2036
Option term for director grant
Underlying shares
48,800 shares
Common stock underlying stock option award
Vesting schedule
12 monthly installments
Vests over 12 months following May 1, 2026
Post-transaction option holdings (this grant)
48,800 options
Total options following transaction for this award
Key Terms
non-employee director compensation policy, stock options, vested and exercisable, underlying security
4 terms
non-employee director compensation policy financial
"The options were granted pursuant to the Company's non-employee director compensation policy."
stock options financial
"Stock Options (option to buy)"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vested and exercisable financial
"The shares underlying the option become vested and exercisable in substantially equal monthly installments"
underlying security financial
"underlying_security_title": "Common Stock, par value $0.0001""
FAQ
What insider transaction did Altimmune (ALT) director Philip Hodges report?
Philip Hodges reported receiving a grant of stock options for 48,800 shares of Altimmune common stock. The options were awarded as part of the company’s non-employee director compensation policy and represent a compensation grant, not an open-market stock purchase or sale.
What is the exercise price and expiration date of Philip Hodges’ Altimmune options?
The options have an exercise price of $2.82 per share and expire on May 1, 2036. This means Hodges can, once vested, buy Altimmune common stock at $2.82 per share any time before the options expire, subject to plan and agreement terms.
How do Philip Hodges’ Altimmune options vest over time?
The 48,800 options vest and become exercisable in substantially equal monthly installments over the 12 months following May 1, 2026. Vesting is contingent on Hodges’ continued service with Altimmune through each applicable vesting date, aligning compensation with ongoing board service.